| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T80 |
0-94 |
Sentence |
denotes |
Cell type Dosage Number of patients Outcome Stage of study Reference or NCT numbers# |
| T81 |
95-397 |
Sentence |
denotes |
MSCs (tissue source unspecified) Single dose of 1 × 106 cells per kg, IV 7 patients with severe COVID-19 pneumonia Regulation of inflammatory response (Decreased plasma C-reaction protein, reduced cytokine-secreting immune cells, reduced TNF-α, increased IL-10 and VEGF) Complete Leng et al., 2020 |
| T82 |
398-485 |
Sentence |
denotes |
Adipose tissue-derived MSCs Two serial doses of 1.5 × 106 cells per kg, IV Estimated: |
| T83 |
486-545 |
Sentence |
denotes |
100 patients N/A Phase 2; Not yet recruiting NCT04348461 |
| T84 |
546-617 |
Sentence |
denotes |
Dental pulp stem cells 3 × 107 cells IV on day 1, 4, and 7 Estimated: |
| T85 |
618-683 |
Sentence |
denotes |
20 patients N/A Phase 1 clinical trial; recruiting NCT04336254 |
| T86 |
684-762 |
Sentence |
denotes |
Dental pulp stem cells 1 × 106 cells per kg IV on day 1, 3, and 7 Estimated: |
| T87 |
763-827 |
Sentence |
denotes |
24 patients N/A Early Phase 1; Not yet recruiting NCT04302519 |
| T88 |
828-926 |
Sentence |
denotes |
Wharton's Jelly MSCs 3 doses of 1 × 106 cells per kg IV, 3 days apart from each other Estimated: |
| T89 |
927-991 |
Sentence |
denotes |
5 patients N/A Phase 1 clinical trial; recruiting NCT04313322 |
| T90 |
992-1073 |
Sentence |
denotes |
MSCs (tissue source unspecified) 3 × 107 cells IV on day 0, 3, and 6 Estimated: |
| T91 |
1074-1139 |
Sentence |
denotes |
20 patients N/A Phase 1 clinical trial; recruiting NCT04252118 |
| T92 |
1140-1213 |
Sentence |
denotes |
Umbilical cord MSCs 9.9 × 107 cells IV on day 1, 3, 5, and 7 Estimated: |
| T93 |
1214-1279 |
Sentence |
denotes |
10 patients N/A Phase 2 clinical trial; recruiting NCT04269525 |
| T94 |
1280-1372 |
Sentence |
denotes |
Umbilical cord MSCs 0.5 × 106 cells per kg body weight IV on day 1, 3, 5, and 7 Estimated: |
| T95 |
1373-1422 |
Sentence |
denotes |
48 patients N/A Not yet recruiting NCT04273646 |
| T96 |
1423-1492 |
Sentence |
denotes |
Bone Marrow MSCs Single dose of 1 × 106 cells per kg, IV Estimated: |
| T97 |
1493-1566 |
Sentence |
denotes |
20 patients N/A Phase 1 clinical trial; Not yet recruiting NCT04346368 |
| T98 |
1567-1717 |
Sentence |
denotes |
Human embryonic stem cells derived matrix-regulatory cells 3 cohorts who receive doses of 3, 5, or 10 million cells per kg body weight IV Estimated: |
| T99 |
1718-1782 |
Sentence |
denotes |
9 patients N/A Phase 1 clinical trial; recruiting NCT04331613 |
